SavedAdd your journal

Journals / Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2014 / Cilt: 25 - Sayı: 1

Which treatment reaches glycemic goals in type-2 diabetic patients?

Tip 2 diyabetik hastalarda hangi tedavi ile glisemik hedeflere ulaştık?

Mustafa TEKÇE
Mehmet ALİUSTAOĞLU
Ercan ERGİN
Seydahmet AKIN
Muhammet Emin ERDEM
Ersin EFETÜRK
Pages
13–18
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In good glycemic control group, we unexpectedly observed that there were more patients under OAD medication than patients un- der insulin therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: This study evaluates the rate of reaching glyce- mic goals in patients with type-2 diabetes admitted to outpa- tient clinic of our internal medicine department and their medi- cation profile.
📊
Key Findings & Data:Methods: A total of 375 diabetic patients visited the outpa- tient clinic of Internal Medicine Department within 3 months between March 2011 and May 2011.
💡
Conclusion & Impact:In good glycemic control group, we unexpectedly observed that there were more patients under OAD medication than patients un- der insulin therapy.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: This study evaluates the rate of reaching glyce- mic goals in patients with type-2 diabetes admitted to outpa- tient clinic of our internal medicine department and their medi- cation profile. Methods: A total of 375 diabetic patients visited the outpa- tient clinic of Internal Medicine Department within 3 months between March 2011 and May 2011. HbA1c levels, age of the patients, and medication were investigated. Medication pro- files of the patients with HbA1c levels of ≤7% (good glycemic control group) were evaluated. Results: Regardless of age, 66% of all patients (n=248) were in good glycemic control group. In patients that reached gly- cemic goal, 81% of them were using oral antidiabetics (OADs) (n=203); 15% of them (n=36) were using OADs and insulin; and only 4% of them (n=9) were using insulin. There were 169 patients who had diabetes 5 years or longer; in these patients, good glycemic control was seen in 36% of them (n=36). In these patients, 98% of them (n=61) were using OADs, and only 1 pa- tient (2%) was using insulin and OADs. Conclusion: In the diabetic population, increased disease du- ration is correlated with decreased glycemic control. In good glycemic control group, we unexpectedly observed that there were more patients under OAD medication than patients un- der insulin therapy.

Özet

Amaç: Bu çalışmada hastanemiz dahiliye polikliniğine baş- vuran tip 2 diyabetli hastalarında glisemik hedeflere ulaşma oranları ve glisemik hedefe ulaşanların ilaç kullanım profille- ri incelenmiştir. Gereç ve Yöntem: Mart 2011-Mayıs 2011 arasında üç ay bo- yunca hastanemiz İç Hastalıkları Polikliniğine başvuran 375 tip 2 diyabet tanılı hastanın HbA1c değerlerine bakıldı, has- talık yaşı ve ilaç kullanımı sorgulandı. HbA1c ≤%7 olan has- taların (iyi kontrol grubu) ilaç profilleri incelendi. Bulgular: Üç yüz yetmiş beş hastanın hastalık yaşı dikkate alınmadan değerlendirildiğinde %66sı (n=248) iyi kont- rol grubunda idi. Glisemik hedefe ulaşmış bu hastaların %81i oral antidiyabetik (OAD) (n=203), %15i OAD + insülin (n=36), %4ü sadece insülin (n=9) kullanmaktaydı. Hastalık yaşı beş yıl ve üzeri olan hastaları incelendiğimizde (n=169) ise 169 hastanın %36sı iyi kontrol grubunda idi (n=61). Gli- semik hedefe ulaşmış bu hastaların %98i OAD (n=60), %2si OAD + insülin (n=1) kullanmaktaydı. Sonuç: Diyabetik popülasyonda hastalık yaşı ilerledikçe iyi kontrol grubu oranı azalmaktadır. İyi kontrol grubunda has- talık yaşı ilerledikçe insülin kullanımının artması beklenirken çalışmamızda oral antidiyabetik kullanan hastaların daha fazla olduğunu tespit ettik.

🔖

Cite This Article

TEKÇE, M., ALİUSTAOĞLU, M., ERGİN, E., AKIN, S., ERDEM, M. E., EFETÜRK, E. (2022). Which treatment reaches glycemic goals in type-2 diabetic patients?. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 25 - Sayı: 1, 13–18. https://ajindex.com/articles/571349

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Zimmet P, Williams J, de Courten M. Diagnosis and clas- sification of diabetes mellitus. In: Wass JAM, Shalet SM, Gale E, Amiel S, editors. Oxford Textbook of Endocrinol- ogy and Diabetes. Oxford, New York: Oxford University Press; p. 1635-46
  2. International Diabetes Federation. Diabetes Atlas, 4th ed. Brussels; 2009
  3. Sekikawa A, LaPorte RE. Epidemiology of insulin de- pendent diabetes mellitus. In: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H, editors. International Textbook of Diabetes Mellitus. 2nd ed. Vol. I, New York: John Wiley & Sons Ltd; 1997. p. 89-96
  4. Satman I, Yılmaz MT, Şengül AM, Salman S, Salman F, Uygur S, et al. and the TURDEP group: Population based study of diabetes and the risk chracteristics: final results of the TURDEP. Diabetologia 2000;43(Suppl 1);A111
  5. Satman I, editor. TURDEP-II Sonuçları. Türk Endokronoloji ve Metabolizma Derneği [homepage on the Internet]. Avaible from: http://www.turkendokrin.org/fi les/fi le/ TURDEP_ II_2011.pdf Last access: 16th May 2011
  6. Wild S, Roglic G, Green A, Sicree R, King H. Global preva- lence of diabetes: estimates for the year 2000 and pro- jections for 2030. Diabetes Care 2004;27(5):1047-53
  7. International Diabetes Federation. Diabetes Atlas. 3rd ed. Brussels, International Diabetes Federation, 2006
  8. Ekoe JM. Diabetes mellitus: aspects of the worldwide epidemiology of diabetes mellitus and its long-term complications. New York: Elsevier; 1988
  9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Educa- tion Program (NCEP) Expert Panel on Detection, Evalua- tion, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97
  10. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Ef- fects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20(4):537-44
  11. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343-50
  12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393-403
  13. Diabetes mellitus. Report of a WHO Study Group. Wo